Sermorelin Before and After: What Results Are Plausible and What Photos Hide

Before-and-after photographs are the dominant marketing for sermorelin, and they are the least reliable evidence available for anything. That is worth establishing before discussing what the compound can plausibly do — because the two questions get answered with the same images.

What sermorelin actually is

Sermorelin is the first 29 amino acids of growth hormone-releasing hormone — the fragment that retains biological activity. It stimulates the pituitary to release growth hormone rather than supplying growth hormone directly.

Why before-and-after photos prove very little

1. Lighting, posture and angle change apparent body composition more than months of intervention typically do. The "after" is rarely shot under the same conditions.

2. Selection. You are shown the responders. Nobody publishes the photos where nothing changed, and there is no way to know what fraction those represent.

3. Confounding. People starting a peptide protocol usually change training, diet and sleep at the same time. Those interventions have well-established effects on body composition.

4. Time of day and hydration. Abdominal appearance varies substantially within a single day.

5. Tanning, grooming, and pump. All routinely differ between the two images, and all change apparent definition.

6. No measurement. A photograph is not DEXA, not a lipid panel, and not an IGF-1 level.

What the mechanism can plausibly produce

Raising growth hormone has recognised physiological effects, so the plausible outcomes are not zero. They are also narrower and slower than the marketing suggests.

Tesamorelin is the useful comparator here. It is a GHRH analogue with a current approval, and its approved indication is specifically visceral adipose tissue reduction in HIV-associated lipodystrophy — a narrow, measured effect established over months in trials. That is what a GHRH analogue looks like when its effect is properly quantified. See tesamorelin vs sermorelin.

The pituitary dependency

Sermorelin only works through a pituitary capable of responding. Its effect therefore depends on baseline function, which varies with age and between individuals — and is not measured before most people start.

For context on what properly measured GH intervention looks like, a 2026 phase 3 study of once-weekly somatrogon in adults with growth hormone deficiency used a diagnosed population, defined endpoints and randomisation. That is the standard against which photo evidence should be read.

What to measure instead

1. IGF-1 at baseline and on treatment. The standard proxy for GH axis activity, and the closest thing to an objective marker here.

2. Body composition by DEXA rather than by photograph.

3. Fasting glucose and HbA1c. Growth hormone opposes insulin — this is the effect most worth watching and least often mentioned.

4. Sleep, tracked objectively rather than recalled.

5. Consistent photographs if you want them — same lighting, time of day, hydration state and pose. Then they are at least comparable.

The sermorelin dosage guide and sermorelin side effects guide cover the compound itself, and ipamorelin vs sermorelin covers the alternative mechanism.